125 related articles for article (PubMed ID: 30973391)
1. County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma.
Swords DS; Mulvihill SJ; Brooke BS; Stoddard GJ; Firpo MA; Scaife CL
Ann Surg; 2020 Dec; 272(6):1102-1109. PubMed ID: 30973391
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
[TBL] [Abstract][Full Text] [Related]
3. Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma.
Swords DS; Mulvihill SJ; Skarda DE; Finlayson SRG; Stoddard GJ; Ott MJ; Firpo MA; Scaife CL
Ann Surg; 2019 Jan; 269(1):133-142. PubMed ID: 28700442
[TBL] [Abstract][Full Text] [Related]
4. Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis.
McDowell BD; Chapman CG; Smith BJ; Button AM; Chrischilles EA; Mezhir JJ
Ann Surg; 2015 Apr; 261(4):740-5. PubMed ID: 24979599
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma.
Nassour I; Winters SB; Hoehn R; Tohme S; Adam MA; Bartlett DL; Lee KK; Paniccia A; Zureikat AH
J Surg Oncol; 2020 Aug; 122(2):234-242. PubMed ID: 32350882
[TBL] [Abstract][Full Text] [Related]
7. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
Chen HY; Wang X; Zhang H; Liu XB; Tan CL
World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
[TBL] [Abstract][Full Text] [Related]
8. Invasive IPMN and MCN: same organ, different outcomes?
Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
[TBL] [Abstract][Full Text] [Related]
10. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
[TBL] [Abstract][Full Text] [Related]
11. Selecting optimal surgical procedures for intraductal papillary mucinous neoplasm (IPMN): An analysis based on the Surveillance, Epidemiology, and End Result registry database.
Wang X; Hong X; Pang H; Dai H; You L; Wu W; Zhao Y
Eur J Surg Oncol; 2016 Oct; 42(10):1526-32. PubMed ID: 27436161
[TBL] [Abstract][Full Text] [Related]
12. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
[TBL] [Abstract][Full Text] [Related]
13. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
[No Abstract] [Full Text] [Related]
14. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
[TBL] [Abstract][Full Text] [Related]
15. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
16. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.
Gaitanidis A; Alevizakos M; Tsaroucha A; Tsalikidis C; Simopoulos C; Pitiakoudis M
Eur J Surg Oncol; 2018 May; 44(5):693-699. PubMed ID: 29426780
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
18. The importance of surgical margins in pancreatic cancer.
Ethun CG; Kooby DA
J Surg Oncol; 2016 Mar; 113(3):283-8. PubMed ID: 26603829
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
Fukumoto T; Watanabe T; Hirai I; Kimura W
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
